Use of octreotide for relief of gastro-intestinal (GI) symptoms in systemic mastocytosis

Hematol Oncol Stem Cell Ther. 2013 Jun;6(2):72-5. doi: 10.1016/j.hemonc.2013.05.003. Epub 2013 May 24.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Bone Marrow / pathology
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Gastrointestinal Diseases / complications
  • Gastrointestinal Diseases / diagnosis
  • Gastrointestinal Diseases / drug therapy*
  • Humans
  • Mast Cells / immunology
  • Mast Cells / metabolism
  • Mast Cells / pathology
  • Mastocytosis, Systemic / complications
  • Mastocytosis, Systemic / diagnosis*
  • Octreotide / therapeutic use*
  • Tomography, X-Ray Computed

Substances

  • Gastrointestinal Agents
  • Octreotide